We are live on ! Find out more
BAMS

Bellevue Asset Management (Switzerland) Portfolio holdings

AUM $656M
1-Year Est. Return 11.45%
This Fund
S&P 500
This Quarter Est. Return
+10.91%
1 Year Est. Return
+11.45%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$656M
AUM Growth
+$43.2M
Cap. Flow
-$10.7M
Cap. Flow %
-1.63%
Top 10 Hldgs %
31%
Holding
140
New
7
Increased
40
Reduced
26
Closed
13

Top Buys

Rank Stock Value
1
CAH icon
Cardinal Health
CAH
+$7.77M
2
CNC icon
Centene
CNC
+$5.07M
3
LCI
Lannett Company, Inc.
LCI
+$4.41M
4
VTRS icon
Viatris
VTRS
+$4.34M
5
CVS icon
CVS Health
CVS
+$4.04M

Top Sells

Rank Stock Value
1
AGN
Allergan plc
AGN
+$13.6M
2
RDY icon
Dr. Reddy's Laboratories
RDY
+$8.31M
3
KITE
Kite Pharma, Inc.
KITE
+$7.43M
4
THC icon
Tenet Healthcare
THC
+$3.82M
5
ABT icon
Abbott
ABT
+$3.6M

Sector Composition

Rank Sector Weight
1 Healthcare 93.1%
2 Financials 1.62%
3 Industrials 0.28%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ALDR
101
DELISTED
Alder Biopharmaceuticals
ALDR
$1.09M 0.17%
33,000
-10,000
-23% -$338K
EXEL icon
102
Exelixis
EXEL
$14.3B
$959K 0.15%
170,000
+20,000
+13% +$112K
ESPR
103
DELISTED
Esperion Therapeutics
ESPR
$890K 0.14%
40,000
– –
ABBV icon
104
AbbVie
ABBV
$435B
$889K 0.14%
15,000
-12,000
-44% -$691K
KITE
105
DELISTED
Kite Pharma, Inc.
KITE
$863K 0.13%
14,000
-105,500
-88% -$7.43M
IBB icon
106
iShares Biotechnology ETF
IBB
$9.47B
$846K 0.13%
7,500
– –
AFFX
107
DELISTED
Affymetrix Inc
AFFX
$807K 0.12%
80,000
– –
RMD icon
108
ResMed
RMD
$32.5B
$805K 0.12%
15,000
– –
PODD icon
109
Insulet
PODD
$9.23B
$794K 0.12%
21,000
-1,500
-7% -$50.5K
IPXL
110
DELISTED
Impax Laboratories, Inc.
IPXL
$770K 0.12%
18,000
– –
TMH
111
DELISTED
Team Health Holdings Inc
TMH
$658K 0.1%
15,000
– –
MYGN icon
112
Myriad Genetics
MYGN
$301M
$604K 0.09%
14,000
-19,000
-58% -$803K
ABUS icon
113
Arbutus Biopharma
ABUS
$913M
$556K 0.08%
125,000
– –
JNP
114
DELISTED
Juniper Pharmaceuticals, Inc. Common Stock
JNP
$515K 0.08%
50,000
– –
CSII
115
DELISTED
Cardiovascular Systems, Inc.
CSII
$454K 0.07%
30,000
– –
MNKD icon
116
MannKind Corp
MNKD
$1.27B
$435K 0.07%
60,000
– –
IMGN
117
DELISTED
Immunogen Inc
IMGN
$407K 0.06%
30,000
– –
ECYT
118
DELISTED
Endocyte, Inc. Common Stock
ECYT
$401K 0.06%
100,000
-58,000
-37% -$267K
THC icon
119
Tenet Healthcare
THC
$21.1B
$303K 0.05%
10,000
-116,510
-92% -$3.82M
XOMA
120
DELISTED
Xoma
XOMA
$299K 0.05%
11,250
– –
HTWR
121
DELISTED
HEARTWARE INTERNATIONAL INC COM STK (DE)
HTWR
$252K 0.04%
5,000
-40,000
-89% -$1.88M
TTPH
122
DELISTED
Tetraphase Pharmaceuticals, Inc.
TTPH
$221K 0.03%
1,100
– –
GERN icon
123
Geron
GERN
$1.05B
$218K 0.03%
45,000
– –
TBPH icon
124
Theravance Biopharma
TBPH
$876M
$187K 0.03%
11,428
– –
EIGR
125
DELISTED
Eiger BioPharmaceuticals, Inc.
EIGR
$74K 0.01%
111
– –
2 3 4
5
6

Similar funds

VFAM
Valley Forge Asset Management King Of Prussia, Pennsylvania $645M AUM 5.8% 1-Year Est. Return
MSU
Maple Securities USA Jersey City, New Jersey $672M AUM 1.03% 1-Year Est. Return
PSI
Pinnacle Summer Investments Fairfax, Virginia $678M AUM 9.54% 1-Year Est. Return
SFP
Santa Fe Partners Santa Fe, New Mexico $608M AUM 8.76% 1-Year Est. Return
MCM
Mazama Capital Management Portland, Oregon $544M AUM 9.52% 1-Year Est. Return
NMIS
Northwestern Mutual Investment Services Milwaukee, Wisconsin $525M AUM 2.45% 1-Year Est. Return
SM
Stratton Management King Of Prussia, Pennsylvania $824M AUM 1.55% 1-Year Est. Return
ZAM
Zenit Asset Management Stockholm, Sweden $450M AUM 8.32% 1-Year Est. Return

Bellevue Asset Management (Switzerland)'s Q4 2015 Portfolio in Review

As of Q4 2015, Bellevue Asset Management (Switzerland) held 140 positions worth $656M, up 7% from $613M the previous quarter. Its ten largest holdings account for 31% of the portfolio.

Bellevue Asset Management (Switzerland)'s Q4 2015 filing shows 7 new, 40 increased, 26 reduced and 13 closed positions. Its largest new stake was Lannett Company, Inc.: 26,870 shares worth $4.31M. The largest sale was Allergan plc, an estimated $13.6M.

By sector, the portfolio is most concentrated in Healthcare at 93% of assets, up from 92% a quarter earlier, followed by Financials and Industrials.

  • Bellevue Asset Management (Switzerland)'s largest Q4 2015 buy was Lannett Company, Inc.: 26,870 shares worth $4.31M.
  • Bellevue Asset Management (Switzerland) added most to Cardinal Health in Q4 2015, an estimated $7.77M increase.
  • Bellevue Asset Management (Switzerland)'s biggest Q4 2015 reduction was Kite Pharma, Inc., cutting an estimated $7.43M.
  • Bellevue Asset Management (Switzerland) fully exited Allergan plc in Q4 2015, selling an estimated $13.6M.
  • Bellevue Asset Management (Switzerland)'s ten largest holdings make up 31% of its $656M portfolio in Q4 2015.
  • Bellevue Asset Management (Switzerland) opened 7 new positions and closed 13 in Q4 2015.
  • Bellevue Asset Management (Switzerland)'s portfolio value rose 7% quarter-over-quarter to $656M.

Based on Bellevue Asset Management (Switzerland)'s 13F filing for Q4 2015, filed 12 Feb 2016.